Table 1 Clinical characteristics of patient cohort.
Short-term (ST) | Long-term (LT) | |
---|---|---|
Patients (no.) | n = 23 | n = 16 |
Tumors | 46 | 32 |
Primary | 23 | 16 |
Metastatic | 23 | 16 |
Age (years) | 61.5 ± 19.5 | 57 ± 8.2 |
FIGO stage | ||
IIIA | 2 | 0 |
IIIC | 14 | 16 |
IV | 7 | 0 |
FIGO grade | ||
Moderately differentiated | 3 | 0 |
Poorly differentiated | 20 | 16 |
Histology | ||
Serous | 22 | 16 |
Endometrioid | 1 | 0 |
Median overall survival (OS) (months) | 21 (range: 0–41) | 111 (range: 82–195) |
Fresh frozen (FF) samples | ||
Primary | 17 | 0 |
Metastatic | 11 | 0 |
Paraffin-fixed (FFPE) samples | ||
Primary | 6 | 16 |
Metastatic | 12 | 16 |
Whole-exome sequenced | 46 | 14 |
RNA-sequenced | 46 | 14 |